Search

BIO DESIGN

pISSN 2288-6982
eISSN 2288-7105

Article

Article

Article

Bio Design 2020; 8(3): 55-59

Published online September 30, 2020

https://doi.org/10.34184/kssb.2020.8.3.55

© Korean Society for Structural Biology

A novel allosteric inhibitor of protein tyrosine phosphatase sigma

Mi Rae Kim, Myeongbin Kim and Seong Eon Ryu*

Department of Bioengineering, College of Engineering, Hanyang University, Seoul 04763, Republic of Korea

Correspondence to: ryuse@hanyang.ac.kr

Received: August 13, 2020; Revised: September 11, 2020; Accepted: September 17, 2020

Abstract

Protein tyrosine phosphatases (PTPs), along with protein kinases, mediate phosphorylation signaling in cells and are involved in cancers, diabetes, neural disorders, and immunological diseases. PTP sigma (PTPσ) is a receptor-type PTP with a C-terminal cytoplasmic region being responsible for its enzymatic activity. The inhibitors of the PTPσ catalytic activity promote neural cell growth and hematopoietic stem cell proliferation. In this study, we performed chemical library screening to identify a novel allosteric inhibitor PTPσ and characterized the inhibitor-enzyme interaction. Based on the analyses, we found a novel allosteric inhibitor that binds to a pocket between the two catalytic domains of the cytoplasmic region of PTPσ. Site directed mutagenesis studies identified residues involved in the inhibitor binding and enzyme kinetics experiments proved the allosteric mode of inhibition. The allosteric regulation site in the domain interface could be exploited to develop specific inhibitors for disease therapeutics.